Target intelligence / Profile preview

PorA protein (Major outer membrane protein, formerly class 1 protein) from Neisseria meningitidis (PorA)

Target
PorA
Molecular classification
Porin, Outer membrane protein, Vaccine antigen
01

Overview

The PorA protein is a major surface-exposed outer membrane porin in *Neisseria meningitidis* serogroup B. It forms cation-selective channels responsible for nutrient uptake and is a key target of bactericidal antibodies elicited by infection or vaccination. PorA is highly variable, with different subtypes defined by sequence differences in surface-exposed loop regions, leading to strain-specific immune responses. It is included in OMV-based vaccines, but antigenic and phase variation restricting surface expression complicate broad protection. OMV vesicles themselves contain many additional proteins, but PorA remains the principal vaccine antigen for group B disease.

Other names
Class 1 outer membrane proteinmeningococcal PorANeisseria meningitidis PorAmajor outer membrane protein P1
02

Mechanism of action

Induction of protective antibody response targeting PorA, leading to opsonophagocytosis and complement-mediated bacterial killing

03

Biological functions

Nutrient transportImmune response
04

Disease associations

InfectionOther
05

Safety considerations

Antigenic variation of PorA among strains (limits cross-strain protection, requiring multivalent vaccines)Phase variation/variable expression, allowing immune escape by altered PorA expression
06

Interacting drugs

Meningococcal group B vaccines
07

Biomarkers

PorA protein variants/subtypes (P1.X, P1.X,X) in bacterial isolatesSerum bactericidal antibody titers against PorA

Beyond the preview

Go deeper on PorA protein (Major outer membrane protein, formerly class 1 protein) from Neisseria meningitidis (PorA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PorA protein (Major outer membrane protein, formerly class 1 protein) from Neisseria meningitidis (PorA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call